<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29217999</article-id>
<article-id pub-id-type="pmc">5703699</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2017.00360</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Prytkova</surname>
<given-names>Iya</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/468300/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brennand</surname>
<given-names>Kristen J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/143696/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neuroscience, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>line&gt;New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff4"><sup>4</sup><institution>Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Psychiatry, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <italic>Chao Deng, University of Wollongong, Australia</italic></p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <italic>Tomiki Sumiyoshi, National Center of Neurology and Psychiatry, Japan; Stewart Alan Anderson, University of Pennsylvania, United States; Yuriko Iwakura, Niigata University, Japan</italic></p>
</fn>
<corresp id="fn001">*Correspondence: <italic>Kristen J. Brennand, <email xlink:type="simple">kristen.brennand@mssm.edu</email></italic></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>11</volume>
<elocation-id>360</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Prytkova and Brennand.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Prytkova and Brennand</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Excitatory dopaminergic neurons, inhibitory GABAergic neurons, microglia, and oligodendrocytes have all been implicated in schizophrenia (SZ) network pathology. Still, SZ has been a difficult disorder to study, not only because of the limitations of animal models in capturing the complexity of the human mind, but also because it is greatly polygenic, with high rates of variability across the population. The advent of patient-derived pluripotent stem cells and induced neural and glial cultures has brought hope for modeling the molecular dysfunction underlying SZ pathology in a patient-specific manner. Here I review the successes of the patient-specific induced cultures in generating different cell types for the study of SZ, with special emphasis on the utility of co-culture techniques, both two- and three-dimensional, for modeling network dysfunction in disease.</p>
</abstract>
<kwd-group>
<kwd>human induced pluripotent stem cells</kwd>
<kwd>induced neurons</kwd>
<kwd>co-culture</kwd>
<kwd>organoids</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
<award-id rid="cn001">R01 MH101454</award-id>
<award-id rid="cn001">R01 MH106056</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Brain and Behavior Research Foundation<named-content content-type="fundref-id">10.13039/100000874</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn003">Brain Research Foundation<named-content content-type="fundref-id">10.13039/100000882</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn004">New York Stem Cell Foundation<named-content content-type="fundref-id">10.13039/100003194</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="84"></ref-count>
<page-count count="8"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Schizophrenia (SZ) is a common debilitating psychiatric disorder which affects approximately 1% of the world population and accounts for a significant socio-economic burden (<xref ref-type="bibr" rid="B65">Rössler et al., 2005</xref>). The disease is characterized by the presence of positive symptoms, such as hallucinations, delusions, and paranoia, and negative symptoms, such as social withdrawal and flattened affect; SZ is also marked by cognitive deficits such as disorganized thoughts and difficulty concentrating (<xref ref-type="bibr" rid="B6">Barnhill, 2013</xref>). The symptoms may appear in a variety of constellations. Additionally, individuals with SZ have a high risk of suicide, high prevalence of substance abuse, and a high rate of homelessness (<xref ref-type="bibr" rid="B65">Rössler et al., 2005</xref>). Despite being recognized as early as 1896 (<xref ref-type="bibr" rid="B65">Rössler et al., 2005</xref>), disease etiology has remained elusive. The rate of heritability has been estimated to be around 80%, but the concordance rate among monozygotic twins is around 50% (<xref ref-type="bibr" rid="B15">Cardno et al., 1999</xref>), indicating that genetic contribution alone is insufficient to fully account for disease risk. Moreover, genome wide associated studies (GWAS) by the <xref ref-type="bibr" rid="B66">Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014)</xref> have identified over one hundred loci associated with the disease, consistent with the clinical heterogeneity of the disorder.</p>
</sec>
<sec>
<title>Network Dysfunction In Schizophrenia</title>
<p>Overwhelming genetic evidence now demonstrates that SZ is a complex genetic disorder (<xref ref-type="bibr" rid="B66">Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014</xref>) reflecting cumulative risk from more than 100 rare and common variants. Although the genetic and symptomatic heterogeneity of SZ implicates a wide variety of neurotransmitter, neuroimmune, neuroanatomical, and neurodevelopmental processes (reviewed xx), the precise cell type(s) responsible for the cell autonomous defects underlying the earliest disease processes remain unresolved. Historically, the effectiveness of D<sub>2</sub>-receptor antagonists as anti-psychotics shaped much of the thinking surrounding the neurobiological mechanisms of SZ (<xref ref-type="bibr" rid="B23">Delay et al., 1952</xref>; <xref ref-type="bibr" rid="B16">Carlsson et al., 1957</xref>); while successful in some cases at alleviating the positive and, to a lesser extent (<xref ref-type="bibr" rid="B41">Kirkpatrick et al., 2001</xref>), negative symptoms of SZ, these drugs produce a plethora of side effects which lead to high rates of discontinuation (<xref ref-type="bibr" rid="B45">Lieberman et al., 2005</xref>). Glutamatergic signaling via <italic>n</italic>-methyl-<sc>D</sc>-aspartate receptor (NMDA-R) has also been repeatedly linked to disordered cognition and sensory processing (for review see <xref ref-type="bibr" rid="B39">Kantrowitz and Javitt, 2012</xref>); NMDA-R antagonists, such as phencyclidine and ketamine, mimic some cognitive and behavioral symptoms of SZ (<xref ref-type="bibr" rid="B40">Kehrer et al., 2008</xref>). Another possibility is that the loss of NMDA receptors on GABAergic interneurons leads to hyper-activation of cortical forebrain neurons (<xref ref-type="bibr" rid="B56">Olney et al., 1999</xref>), thus leading to an overall excitation/inhibition imbalance (<xref ref-type="bibr" rid="B36">Homayoun and Moghaddam, 2007</xref>). Since glutamatergic signaling on GABAergic interneurons has an important regulatory function on the activity of dopaminergic neurons, it seems reasonable that genetic variants impacting any (or all) of these cell types could lead to convergent elements of symptomology across genetically heterogeneous patients.</p>
<p>There is a strong neurodevelopmental component to SZ risk (<xref ref-type="bibr" rid="B77">Weinberger, 1995</xref>). Most cases of SZ are diagnosed in adolescence or young adulthood (<xref ref-type="bibr" rid="B44">Lewis and Lieberman, 2000</xref>), although there are rare cases of childhood onset (<xref ref-type="bibr" rid="B4">Asarnow, 1994</xref>). During these stages of development, extensive synaptic pruning and overall loss of gray matter occurs (<xref ref-type="bibr" rid="B38">Huttenlocher and Dabholkar, 1997</xref>). Neuroimaging studies have shown a loss of frontal and hippocampal volume in SZ patients; post-mortem tissue analyses have further identified decreased spine density and synaptic connectivity (<xref ref-type="bibr" rid="B31">Glantz and Lewis, 2000</xref>; <xref ref-type="bibr" rid="B49">McGlashan and Hoffman, 2000</xref>; <xref ref-type="bibr" rid="B27">Faludi and Mirnics, 2011</xref>). Microglia and oligodendrocytes have also been implicated in SZ pathology, due to their roles in synaptic pruning (<xref ref-type="bibr" rid="B59">Paolicelli et al., 2011</xref>) and cell-to-cell communication (<xref ref-type="bibr" rid="B74">Tkachev et al., 2003</xref>), respectively.</p>
<p>The limitations of animal models in re-capitulating human development, the heterogeneity of this complex genetic disorder, and the variable response to pharmacological therapies underscore the necessity for modeling SZ in human cells. Neurons and glia derived from human induced pluripotent stem cells (hiPSCs) offer an opportunity to investigate the complex cellular and molecular interactions involved in SZ. Despite the fairly recent advent of hiPSCs in <xref ref-type="bibr" rid="B71">Takahashi et al. (2007)</xref>, numerous advances have facilitated improved reprogramming of patient somatic cells into neurons, either directly or via a pluripotent stem cell intermediate. Below I review the available protocols for generating various neuronal cultures, with a focus on the application of each method to modeling cellular dysfunction in SZ. Finally, I address current limitations and future strategies to improve upon this approach.</p>
</sec>
<sec>
<title>Patient hiPscs-Derived Brain Cells for Modeling Schizophrenia</title>
<p>Cellular and molecular dysfunction in SZ has traditionally been studied by examining post-mortem patient brain tissue or through animal models. Post-mortem tissue studies are limited by degradation of key biomolecules (i.e., RNA, DNA, proteins, epigenetic marks) due to delays between death and sample processing (<xref ref-type="bibr" rid="B29">Ferrer et al., 2008</xref>). On the other hand, animal models carry the benefit of <italic>in vivo</italic> manipulations at different developmental stages and isogenic controls. However, animal models of SZ rely either on targeted lesions, administration of psychotropic drugs such as phencyclidine, or on manipulating a single gene associated with the disorder (<xref ref-type="bibr" rid="B12">Brennand and Gage, 2011</xref>; <xref ref-type="bibr" rid="B30">Flores et al., 2016</xref>). These approaches have limited etiological relevance, given the highly polygenic nature of SZ discussed above. By contrast, patient hiPSC-derived neurons and glia offer a unique opportunity to investigate the full genetic landscape contributing to SZ while monitoring neural development (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Recent human induced pluripotent stem cell (hiPSC)-based studies of schizophrenia.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Mutation</th>
<th align="left" colspan="1" rowspan="1" valign="top">Cell type</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reprogramming method</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phenotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamatergic neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Directed differentiation (WNT3A, BDNF, GDNF, cAMP, IGF1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">—</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B61">Pedrosa et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4bp deletion in <italic>DISC1</italic>- frameshift</td>
<td align="left" colspan="1" rowspan="1" valign="top">hiPSC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Integration-free episomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">—</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B20">Chiang et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Not known</td>
<td align="left" colspan="1" rowspan="1" valign="top">Forebrain (glutamatergic and GABAergic) neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline-inducible lentivirus (<italic>OCT4, SOX2, KLF4, c-MYC, LIN28</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased neuronal connectivity, increased <italic>NRG1</italic> expression; Loxapine rescue</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B11">Brennand et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">shRNA NRXN1 knock-down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pggy-Bac transposon (OCT4, SOX2, KLF4, c-MYC), then directed differentiation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deficits in astrocyte generation, perturbations in cell adhesion and neuron differentiation pathways</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B83">Zeng et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">15q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NPCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">Integration-free episomes or sendai virus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defects with apical polarity and adherent junctions</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B81">Yoon et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4bp deletion in <italic>DISC1</italic>- frameshift</td>
<td align="left" colspan="1" rowspan="1" valign="top">Forebrain glutamatergic neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Integration-free episomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased soma size and total dendritic length in immature neurons, decreased SV2++ puncti, frequency of sEPSCs and synaptic vesicle release</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B78">Wen et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Not known</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampal dentate gyrus granule neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline-inducible lentivirus (<italic>OCT4, SOX2, KLF4, c-MYC, LIN28</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deficits in generation of DG granule neurons, decreased neuronal activity and sEPSC frequency and amplitude</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B82">Yu et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Integration-free episomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Recapitulation of mRNA and miRNA expression pattern expected of 22q11.2 haploinsufficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B84">Zhao et al., 2015</xref>; <xref ref-type="bibr" rid="B46">Lin et al., 2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NRXN1 hz deletion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamatergic neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline-inducible lentivirus (NGN2) in hESC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decrease in mEPSC frequency and evoked neurotransmitter release; increase in synaptic scaffolding protein CASK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B57">Pak et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Not known</td>
<td align="left" colspan="1" rowspan="1" valign="top">NPCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline-inducible lentivirus (<italic>OCT4, SOX2, KLF4, c-MYC, LIN28</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aberrant migration, increased oxidative stress [mitochondrial membrane potential (MMP)]</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B10">Brennand et al., 2015</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec>
<title>Neural Cultures</title>
<p>Several groups have generated heterogeneous neuronal populations from a variety patient derived hiPSCs, focusing either on genetically defined (<xref ref-type="bibr" rid="B20">Chiang et al., 2011</xref>; <xref ref-type="bibr" rid="B61">Pedrosa et al., 2011</xref>; <xref ref-type="bibr" rid="B78">Wen et al., 2014</xref>) or unknown genetic (<xref ref-type="bibr" rid="B11">Brennand et al., 2011</xref>, <xref ref-type="bibr" rid="B10">2015</xref>) patient cohorts. <xref ref-type="bibr" rid="B20">Chiang et al. (2011)</xref> were the first to report hiPSCs lines from three SZ patients harboring DISC1 mutations, which have been long implicated in SZ and other neuropsychiatric disorders, including autism and major depression. Although this mutation is known to occur in only two rare family pedigrees, the DISC1 protein is thought to bind many proteins involved in neuronal development and synapse formation (<xref ref-type="bibr" rid="B24">Duan et al., 2007</xref>; <xref ref-type="bibr" rid="B62">Porteous et al., 2014</xref>), potentially providing broader insights into disease mechanisms. <xref ref-type="bibr" rid="B78">Wen et al. (2014)</xref> advanced this work by generating fore-brain like neurons from SZ patients with a <italic>DISC1</italic> mutations as well as isogenic hiPSC lines, correcting mutations in one of the patients and introducing frameshift deletions in DISC1 into control hiPSCs. The corrected isogenic lines showed an improvement in synaptic functionality, as evidenced by the increase in synaptic markers (co-localization of SYN1 and PSD95) and increased amplitude and frequency of spontaneous synaptic currents, while the mutated isogenic lines showed a deficit in synaptic activity. The researchers then performed RNA-seq to gain understanding of the affected molecular pathways, and, for the first time, showed differential expression in DISC1-interacting proteins. Moreover, they identified differential regulation of several genes coding for presynaptic proteins (including neurexin 1, synaptophysin, and synaptoporin) and transporters (including MEF2C), implicating mutant DISC1 as a hub of transcriptional regulation (<xref ref-type="bibr" rid="B78">Wen et al., 2014</xref>).</p>
<p>Several copy number variations (CNVs) have been associated with increased SZ risk, including 22q11.2, 15q11.2, and NRXN1 loci (for review see <xref ref-type="bibr" rid="B69">St Clair, 2009</xref>). HiPSC studies of 22q11.2 deletions, found in approximately 1% of SZ cases (<xref ref-type="bibr" rid="B7">Bassett and Chow, 2008</xref>), have identified differential gene expression in pathways regulating cell cycle and development (<xref ref-type="bibr" rid="B46">Lin et al., 2016</xref>) as well as impaired neurite outgrowth and cellular migration (<xref ref-type="bibr" rid="B75">Toyoshima et al., 2016</xref>). Investigation of patient hiPSCs with a 15q11.2 microdeletion revealed deficits in apical polarity and adherens junctions due to CYFIP1 haploinsufficiency; genetic association analyses on these hiPSCs uncovered an epistatic interaction between a WAVE signaling mediator (involved in cytoskeleton development) and CYFIP1 (<xref ref-type="bibr" rid="B81">Yoon et al., 2014</xref>). Finally, NRXN1 expression was reduced in human embryonic stem cells (hESCs) by heterozygous deletion (<xref ref-type="bibr" rid="B57">Pak et al., 2015</xref>) and hiPSCs by shRNA (<xref ref-type="bibr" rid="B83">Zeng et al., 2013</xref>). Heterozygous mutant neurexins resulted in impaired neurotransmitter release and elevation of CASK (synaptic scaffolding protein) (<xref ref-type="bibr" rid="B57">Pak et al., 2015</xref>), and half reduction in NRXN1 expression led to changes in gene expression of cell adhesion and neuron differentiation pathways (<xref ref-type="bibr" rid="B83">Zeng et al., 2013</xref>). These studies highlight the utility of <italic>in vitro</italic> studies for manipulating human genes in human cells and generating human isogenic controls.</p>
<p>By contrast, <xref ref-type="bibr" rid="B11">Brennand et al. (2011)</xref> took a more generalized approach and generated hiPSC-derived neurons from four SZ patients who lacked a unifying genotype, but were selected on the basis of the likelihood of a genetic component to their disease (as supported by relatives affected by psychiatric disease or early age of onset). The group generated a mix of excitatory, inhibitory, and dopaminergic neurons, evidenced by the presence of VGLUT1, GAD67, and tyrosine hydroxylase, respectively. These patient-derived neurons formed fewer processes, exhibited decreased neuronal connectivity (assayed by <italic>trans</italic>-neuronal spread of rabies virus) and decreased spine density (<xref ref-type="bibr" rid="B11">Brennand et al., 2011</xref>). Most strikingly, many of the gene expression pathways perturbed in SZ hiPSC neurons were also detected in immature neural progenitor cells, indicating that these pathways were altered even before the establishment of post-mitotic neurons (<xref ref-type="bibr" rid="B10">Brennand et al., 2015</xref>). Overall, these findings mimic the decreased neuronal connectivity and synaptic function shown in post-mortem tissue studies (16, 33–35).</p>
</sec>
<sec>
<title>Co-culture Systems</title>
<p>The above investigations demonstrate the utility of patient hiPSC-derived neurons for modeling cellular interactions, gaining insight in the impact of a given mutation on said interactions, and elucidating the molecular mechanisms responsible. Most importantly, this is achieved using human cells, thus providing much more translational value than animal models. Despite these advantages, a number of issues surround induced neural protocols (see <xref ref-type="bibr" rid="B26">Engel et al., 2016</xref>), especially in the context of modeling synaptogenesis and network dysfunction. First, gene expression studies indicate hiPSC neurons best resemble fetal brain tissue (<xref ref-type="bibr" rid="B10">Brennand et al., 2015</xref>). Second, hiPSC neurons require extensive cultivation periods of up to 7 months (<xref ref-type="bibr" rid="B48">Maroof et al., 2013</xref>; <xref ref-type="bibr" rid="B54">Nicholas et al., 2013</xref>; <xref ref-type="bibr" rid="B70">Suzuki and Vanderhaeghen, 2015</xref>). Moreover, pure neuronal cultures are limited in their ability to accurately re-capitulate network functionality, since glial cells play an important role in regulating neuronal activity and establishing myelination.</p>
<p>Several groups have developed astrocyte-neuron co-culture systems, using both rodent and human astrocytes with human iPSC-derived neurons, with promising results for maturation and network activity (<xref ref-type="bibr" rid="B73">Tang et al., 2013</xref>; <xref ref-type="bibr" rid="B53">Muratore et al., 2014</xref>; <xref ref-type="bibr" rid="B55">Odawara et al., 2014</xref>; <xref ref-type="bibr" rid="B43">Kuijlaars et al., 2016</xref>). Indeed, the notion that astrocytes enhance synapse maturation is well established from rodent cell cultures (<xref ref-type="bibr" rid="B3">Araque and Perea, 2004</xref>). <xref ref-type="bibr" rid="B55">Odawara et al. (2014)</xref> utilized multiple electrode array (MEA) plates to co-culture rat astrocytes with hiPSC-derived neurons and found increased electrophysiological activity after 3 weeks of plating, with neurons continuing to increase activity for more than 3 months after plating. <xref ref-type="bibr" rid="B53">Muratore et al. (2014)</xref> performed a direct comparison of several neuronal differentiation protocols and demonstrated a significant increase in vGLUT1 expression by day 40 in neurons cultured on mouse astrocytes, pointing to accelerated maturation of excitatory neurons. <xref ref-type="bibr" rid="B43">Kuijlaars et al. (2016)</xref> were the first to utilize astrocyte co-culture with solely human cells in 2016. Using commercially available fetal astrocytes, the group observed synchronized calcium oscillations in hiPSC-derived neurons 3–4 weeks after final plating, indicating sustained network activity (<xref ref-type="bibr" rid="B43">Kuijlaars et al., 2016</xref>).</p>
<p>Although astrocyte co-cultures have yet to be utilized to model neuropsychiatric disease, these studies are very promising, particularly the human-only system employed by <xref ref-type="bibr" rid="B43">Kuijlaars et al. (2016)</xref>. Human neuron-astrocyte co-culture systems may be useful not only for improved neuronal maturation but also for elucidating astrocyte contribution to the disease state, especially taking into consideration the role of astrocytes in modulating synaptic connection and signaling (<xref ref-type="bibr" rid="B32">Goudriaan et al., 2014</xref>). Post-mortem tissue studies have shown decreases in astrocyte density in certain regions (<xref ref-type="bibr" rid="B79">Williams et al., 2013</xref>) and increases in astrocyte markers and neuroinflammation in a subset of patients (<xref ref-type="bibr" rid="B17">Catts et al., 2014</xref>). Co-culturing astrocytes and neurons derived from the same patient may more closely mimic the cellular and molecular dynamics of the individual disease state. Additionally, co-culturing patient astrocytes with healthy control neurons and healthy control astrocytes may help elucidate the contribution of each cell type to SZ etiology.</p>
<p>Oligodendrocyte dysfunction and myelin deficits have also been heavily implicated in SZ by genome association and post-mortem studies (<xref ref-type="bibr" rid="B13">Burns et al., 2003</xref>; <xref ref-type="bibr" rid="B22">Davis et al., 2003</xref>; <xref ref-type="bibr" rid="B74">Tkachev et al., 2003</xref>; <xref ref-type="bibr" rid="B72">Takahashi et al., 2011</xref>; <xref ref-type="bibr" rid="B32">Goudriaan et al., 2014</xref>; <xref ref-type="bibr" rid="B66">Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014</xref>). Specifically, volume reduction in myelin observed in SZ patients is consistent with deficits in neuronal communication and synaptic plasticity thought to underlie SZ pathology (reviewed by <xref ref-type="bibr" rid="B72">Takahashi et al., 2011</xref>). A hiPSC model of patient oligodendrocytes and healthy neurons would allow to investigate the precise consequences of patient-specific variation in oligodendrocyte genes on myelin formation, interactions with neurons, and synaptic plasticity. Additionally, given the well-established role of myelin in neuronal maturation (<xref ref-type="bibr" rid="B33">Hasegawa et al., 1992</xref>), co-culture with oligodendrocytes will likely improve the immature state of current neural hiPSC cultures. Although to date no co-culture system of hiPSC-derived oligodendrocytes and neurons has been reported, oligodendrocytes have been successfully generated from hiPSCs (<xref ref-type="bibr" rid="B47">Livesey et al., 2016</xref>; <xref ref-type="bibr" rid="B25">Ehrlich et al., 2017</xref>). Most excitingly, <xref ref-type="bibr" rid="B25">Ehrlich et al. (2017)</xref> demonstrated successful integration of hiPSC-derived oligodendrocytes into mouse brains, giving hope that this myelination can be reiterated <italic>in vitro</italic> with human cells.</p>
<p>Microglia mediate synaptic pruning during adolescence (<xref ref-type="bibr" rid="B59">Paolicelli et al., 2011</xref>) (although see <xref ref-type="bibr" rid="B67">Sekar et al., 2016</xref> for neuronal contribution to synaptic pruning in SZ) and respond to immune threats by producing inflammatory cytokines (<xref ref-type="bibr" rid="B42">Kreutzberg, 1996</xref>); accordingly, abnormal pruning (<xref ref-type="bibr" rid="B28">Feinberg, 1982</xref>) and neuroinflammation (<xref ref-type="bibr" rid="B5">Ashdown et al., 2005</xref>; <xref ref-type="bibr" rid="B51">Monji et al., 2013</xref>) are thought to contribute to the etiology of SZ. Studying these functions in a hiPSC system would allow scientists to mix and match patient and control microglia and neurons, in order to determine the driving force behind abnormal cellular connectivity and function. Critically, microglia-like cells have been successfully generated from hiPSCs by several groups in the last year (<xref ref-type="bibr" rid="B52">Muffat et al., 2016</xref>; <xref ref-type="bibr" rid="B1">Abud et al., 2017</xref>; <xref ref-type="bibr" rid="B58">Pandya et al., 2017</xref>). These cells resemble fetal and adult human microglia in their gene expression patterns and show phagocytic activity <italic>in vitro</italic> and <italic>in vivo</italic>. A co-culture application for modeling synaptic pruning would benefit from more mature, myelinated neurons; however, hiPSC microglia show potential for modeling inflammatory activation early in development in a co-culture system.</p>
</sec>
<sec>
<title>Modeling Regional Specificity and Circuitry</title>
<p>Although several protocols bias hiPSC differentiation into region-specific neurons, these methodologies fall far short of generating defined circuitry. Typically, hiPSCs are first transformed into neural progenitor cells (NPCs) through dual SMAD inhibition, which involves antagonism of bone morphogenic protein (BMP) and transforming growth factor beta (TGF-β) (<xref ref-type="bibr" rid="B18">Chambers et al., 2009</xref>). Such directed differentiation into NPCs (in contrast to allowing hiPSC colonies to differentiate in neural medium as in the studies by <xref ref-type="bibr" rid="B11">Brennand et al. (2011)</xref> and <xref ref-type="bibr" rid="B61">Pedrosa et al. (2011)</xref> significantly reduces variability in the subsequently derived neurons. The NPCs are then subjected to treatment with growth factors found in distinct regions of the developing brain. Thus, scientists have generated neurons specific to the medial and caudal ganglionic eminences (sites of GABAergic neuron development) (<xref ref-type="bibr" rid="B2">Ahn et al., 2016</xref>), cerebral cortex (<xref ref-type="bibr" rid="B68">Shi et al., 2012</xref>), and the dentate gyrus (<xref ref-type="bibr" rid="B82">Yu et al., 2014</xref>). Although directed-differentiation protocols are thought to more closely mimic <italic>in vivo</italic> development, the protracted timeline poses a major disadvantage. Viral-based induction strategies have been utilized to overexpress exogenous transcription factors to produce excitatory (<xref ref-type="bibr" rid="B35">Ho et al., 2016</xref>) and cortical inhibitory neurons (<xref ref-type="bibr" rid="B21">Colasante et al., 2015</xref>); however, these strategies carry the caveat of additional artificiality and may fail to affect all of the transcription factors necessary to induce regional specificity (see <xref ref-type="bibr" rid="B19">Chanda et al., 2013</xref> and <xref ref-type="bibr" rid="B57">Pak et al., 2015</xref> for evidence on same phenotype across different cell culture methods).</p>
<p>Even with regional specificity and micro-circuit modeling, two-dimensional cultures fail to recapitulate the three-dimensional organization of the brain and circuits therein. The ongoing development of three dimensional neural culture (alternatively called brain organoids or cortical spheroids) shows significant promise for modeling network activity and circuit organization. <xref ref-type="bibr" rid="B60">Paşca et al. (2015)</xref> derived cortical spheres containing non-reactive astrocytes and functional cortical neurons with laminated organization. <xref ref-type="bibr" rid="B63">Qian et al. (2016)</xref> designed a miniature bioreactor system to ensure proper circulation of nutrients in media and produced region-specific organoids that mimicked forebrain, midbrain, and hypothalamus expressing appropriate markers and resembling respective cytoarchitecture. Most recently, <xref ref-type="bibr" rid="B8">Birey et al. (2017)</xref> generated and fused together pallium- and subpallium-resembling organoids to model development and migration of inhibitory neurons. After 3 weeks of contact between the pallium and subpallium (ventral forebrain) organoids, inhibitory neurons from the subpallium sphere migrated into the pallium sphere, yielding functional excitatory and inhibitory post-synaptic connections. Creation of such chimeric organoids is an exciting prospect for modeling developmental cellular migration and connectivity in a 3D system.</p>
<p>Although organoids have yet to be applied to SZ, their potential for modeling neural developmental and electrophysiological anomalies is obvious. Much work remains, however, to adequately model circuit development and contributions of non-neural cells to SZ pathology. Currently, brain organoids contain only relatively immature neurons and non-reactive astrocytes, with oligodendrocytes and microglia still lacking. Potential injection of hiPSC-derived oligodendrocytes and microglia (discussed in the section “Co-culture System”) has promise for incorporation into organoid tissue, and the potential to recapitulate exciting <italic>in vivo</italic> findings that SZ patient hiPSC-derived glial cells function differently when injected into a mouse brain (<xref ref-type="bibr" rid="B80">Windrem et al., 2017</xref>), but differences in growing conditions and developmental requirements still pose major challenges <italic>in vitro</italic>.</p>
<p>While there is solid evidence that the neuropathologies of SZ often precede symptom onset, there are also clear adolescent neurobiological developmental processes (GABAergic maturation, excitatory synaptic pruning, microglia- and astrocyte-mediated neuroinflammation) and environmental exposures (cannabis abuse, stress) that can accelerate or exacerbate genetic risk (well-reviewed <xref ref-type="bibr" rid="B76">van Os et al., 2010</xref>). Moving forward, there is an urgent need to add further complexity to our hiPSC-based models in order to model these additional processes. Such efforts will involve not just improving the complexity of cell types, regional patterning and circuit formation, but also the restoration of critical features of “age” and “maturity” to hiPSC-derived cultures. While reprogramming of fibroblasts into hiPSCs erases age-related epigenetic marks and gene expression profiles, these can be at least partially maintained by inducing patient somatic cells directly into neurons (<xref ref-type="bibr" rid="B50">Mertens et al., 2015</xref>; <xref ref-type="bibr" rid="B37">Huh et al., 2016</xref>). Moreover, some environmental insults may be relatively easy to introduce, such as maternal infection/stress during development (<xref ref-type="bibr" rid="B9">Boksa, 2008</xref>), cannabis use (<xref ref-type="bibr" rid="B34">Henquet et al., 2005</xref>) or hypoxia during delivery (<xref ref-type="bibr" rid="B14">Cannon et al., 2002</xref>), while others such as trauma from childhood abuse and neglect (<xref ref-type="bibr" rid="B64">Read et al., 2005</xref>) may only be vaguely approximated by stress-related molecules such as corticosteroids or inflammatory cytokines.</p>
</sec>
</sec>
<sec>
<title>Concluding Remarks</title>
<p>Despite being in a nascent stage of methodological development, hiPSC-derived neurons show promise for modeling molecular and cellular deficits of SZ. Because of the complex etiology and great genetic variability of the disorder, a patient-specific approach may be illuminating from a mechanistic perspective as well as for drug screening. Already, hiPSC-derived neurons have recapitulated deficits in synaptic maturation and connectivity. Furthermore, advances in generating organoids show promise for modeling network activity in three dimensions, thus better recapitulating brain development and circuitry.</p>
<p>Of course, many limitations accompany the use of tissue culture to model psychiatric disease. Aside from being limited to molecular and cellular phenotypes with no recourse for assessing behavioral consequences, current methods produce immature neurons, limiting studies to the developmental predisposition of disease rather than the actual disease state. Nonetheless, modeling predisposition may uncover targets for preventative therapeutic interventions for patients with a high familial risk of psychiatric disease.</p>
<p>Given the developmental underpinnings and genetic heterogeneity of SZ, hiPSC cultures should complement animal models. Overall, subtype specific hiPSC-derived neuronal and glial (astrocyte, oligodendrocyte, and microglia) culture methods are rapidly evolving. Improved neuronal maturation, combined with novel three dimensional cultures, present an exciting opportunity to investigate circuit function and connectivity in patient-specific cells.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>IP gathered references and wrote the manuscript. KB revised the manuscript and provided additional references.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>KB is a New York Stem Cell Foundation – Robertson Investigator. The Brennand Laboratory is supported by the Brain and Behavior Research Foundation, Brain Research Foundation, NIH grants R01 MH101454 and R01 MH106056, and the New York Stem Cell Foundation. Special thanks to Patricia Casaccia and Anne Schaefer for feedback on this manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abud</surname><given-names>E. M.</given-names></name><name><surname>Ramirez</surname><given-names>R. N.</given-names></name><name><surname>Martinez</surname><given-names>E. S.</given-names></name><name><surname>Healy</surname><given-names>L. M.</given-names></name><name><surname>Nguyen</surname><given-names>C. H. H.</given-names></name><name><surname>Newman</surname><given-names>S. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>iPSC-derived human microglia-like cells to study neurological diseases.</article-title>
<source/><italic>Neuron</italic>
<volume>94</volume>
<issue>278</issue>.<fpage>e9</fpage>–<lpage>293</lpage>.e9. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.042</pub-id>
<pub-id pub-id-type="pmid">28426964</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>T.-G.</given-names></name><name><surname>Kim</surname><given-names>K.-S.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Differentiation of human pluripotent stem cells into Medial Ganglionic Eminence vs. Caudal Ganglionic Eminence cells.</article-title>
<source/><italic>Methods</italic>
<volume>101</volume>
<fpage>103</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2015.09.009</pub-id>
<pub-id pub-id-type="pmid">26364591</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araque</surname><given-names>A.</given-names></name><name><surname>Perea</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Glial modulation of synaptic transmission in culture.</article-title>
<source/><italic>Glia</italic>
<volume>47</volume>
<fpage>241</fpage>–<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20026</pub-id>
<pub-id pub-id-type="pmid">15252813</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asarnow</surname><given-names>J. R.</given-names></name></person-group> (<year>1994</year>). <article-title>Childhood-onset schizophrenia.</article-title>
<source/><italic>J. Child Psychol. Psychiatry</italic>
<volume>35</volume>
<fpage>1345</fpage>–<lpage>1371</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.1994.tb01280.x</pub-id><pub-id pub-id-type="pmid">7868633</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashdown</surname><given-names>H.</given-names></name><name><surname>Dumont</surname><given-names>Y.</given-names></name><name><surname>Ng</surname><given-names>M.</given-names></name><name><surname>Poole</surname><given-names>S.</given-names></name><name><surname>Boksa</surname><given-names>P.</given-names></name><name><surname>Luheshi</surname><given-names>G. N.</given-names></name></person-group> (<year>2005</year>). <article-title>The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>11</volume>
<fpage>47</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001748</pub-id>
<pub-id pub-id-type="pmid">16189509</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Barnhill</surname><given-names>J. W.</given-names></name></person-group> (<year>2013</year>). <article-title>“Schizophrenia spectrum and other psychotic disorders,” in</article-title>
<source/><italic>DSM-5 Clinical Cases. DSM Library</italic>, <role>ed.</role>
<collab>American Psychiatric Association</collab> (<publisher-loc>lake St. Louis, MO</publisher-loc>: <publisher-name>American Psychiatric Publishing)</publisher-name>
<pub-id pub-id-type="doi">10.1176/appi.books.9781585624836.jb02</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>A. S.</given-names></name><name><surname>Chow</surname><given-names>E. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Schizophrenia and 22q11.2 deletion syndrome.</article-title>
<source/><italic>Curr. Psychiatry Rep.</italic>
<volume>10</volume>
<fpage>148</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1007/s11920-008-0026-1</pub-id><pub-id pub-id-type="pmid">18474208</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birey</surname><given-names>F.</given-names></name><name><surname>Andersen</surname><given-names>J.</given-names></name><name><surname>Makinson</surname><given-names>C. D.</given-names></name><name><surname>Islam</surname><given-names>S.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Huber</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Assembly of functionally integrated human forebrain spheroids.</article-title>
<source/><italic>Nature</italic>
<volume>545</volume>
<fpage>54</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1038/nature22330</pub-id>
<pub-id pub-id-type="pmid">28445465</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boksa</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Maternal infection during pregnancy and schizophrenia.</article-title>
<source/><italic>J. Psychiatry Neurosci.</italic>
<volume>33</volume>
<fpage>183</fpage>–<lpage>185</lpage>.<pub-id pub-id-type="pmid">18592037</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennand</surname><given-names>K.</given-names></name><name><surname>Savas</surname><given-names>J. N.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Tran</surname><given-names>N.</given-names></name><name><surname>Simone</surname><given-names>A.</given-names></name><name><surname>Hashimoto-Torii</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>20</volume>
<fpage>361</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.22</pub-id>
<pub-id pub-id-type="pmid">24686136</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennand</surname><given-names>K.</given-names></name><name><surname>Simone</surname><given-names>A.</given-names></name><name><surname>Jou</surname><given-names>J.</given-names></name><name><surname>Gelboin-Burkhart</surname><given-names>C.</given-names></name><name><surname>Tran</surname><given-names>N.</given-names></name><name><surname>Sangar</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Modeling schizophrenia using hiPSC neurons.</article-title>
<source/><italic>Nature</italic>
<volume>473</volume>
<fpage>221</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1038/nature09915</pub-id>
<pub-id pub-id-type="pmid">21490598</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennand</surname><given-names>K. J.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Concise review: the promise of hiPSC-based studies of schizophrenia.</article-title>
<source/><italic>Stem Cells</italic>
<volume>29</volume>
<fpage>1915</fpage>–<lpage>1922</lpage>. <pub-id pub-id-type="doi">10.1002/stem.762</pub-id>
<pub-id pub-id-type="pmid">22009633</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>J.</given-names></name><name><surname>Job</surname><given-names>D.</given-names></name><name><surname>Bastin</surname><given-names>M. E.</given-names></name><name><surname>Whalley</surname><given-names>H.</given-names></name><name><surname>Macgillivray</surname><given-names>T.</given-names></name><name><surname>Johnstone</surname><given-names>E. C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study.</article-title>
<source/><italic>Br. J. Psychiatry</italic>
<volume>182</volume>
<fpage>439</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.182.5.439</pub-id><pub-id pub-id-type="pmid">12724248</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannon</surname><given-names>T. D.</given-names></name><name><surname>van Erp</surname><given-names>T. G.</given-names></name><name><surname>Rosso</surname><given-names>I. M.</given-names></name><name><surname>Huttunen</surname><given-names>M.</given-names></name><name><surname>Lönnqvist</surname><given-names>J.</given-names></name><name><surname>Pirkola</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>59</volume>
<fpage>35</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.59.1.35</pub-id>
<pub-id pub-id-type="pmid">11779280</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardno</surname><given-names>A. G.</given-names></name><name><surname>Marshall</surname><given-names>E. J.</given-names></name><name><surname>Coid</surname><given-names>B.</given-names></name><name><surname>Macdonald</surname><given-names>A. M.</given-names></name><name><surname>Ribchester</surname><given-names>T. R.</given-names></name><name><surname>Davies</surname><given-names>N. J.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>56</volume>
<fpage>162</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.56.2.162</pub-id>
<pub-id pub-id-type="pmid">10025441</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>A.</given-names></name><name><surname>Lindqvist</surname><given-names>M.</given-names></name><name><surname>Magnusson</surname><given-names>T.</given-names></name></person-group> (<year>1957</year>). <article-title>3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.</article-title>
<source/><italic>Nature</italic>
<volume>180</volume>
<issue>1200</issue>
<pub-id pub-id-type="doi">10.1038/1801200a0</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catts</surname><given-names>V. S.</given-names></name><name><surname>Wong</surname><given-names>J.</given-names></name><name><surname>Fillman</surname><given-names>S. G.</given-names></name><name><surname>Fung</surname><given-names>S. J.</given-names></name><name><surname>Shannon Weickert</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Increased expression of astrocyte markers in schizophrenia: association with neuroinflammation.</article-title>
<source/><italic>Aust. N. Z. J. Psychiatry</italic>
<volume>48</volume>
<fpage>722</fpage>–<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1177/0004867414531078</pub-id>
<pub-id pub-id-type="pmid">24744400</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>S. M.</given-names></name><name><surname>Fasano</surname><given-names>C. A.</given-names></name><name><surname>Papapetrou</surname><given-names>E. P.</given-names></name><name><surname>Tomishima</surname><given-names>M.</given-names></name><name><surname>Sadelain</surname><given-names>M.</given-names></name><name><surname>Studer</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.</article-title>
<source/><italic>Nat. Biotechnol.</italic>
<volume>27</volume>
<fpage>275</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id>
<pub-id pub-id-type="pmid">19252484</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>S.</given-names></name><name><surname>Marro</surname><given-names>S.</given-names></name><name><surname>Wernig</surname><given-names>M.</given-names></name><name><surname>Südhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>16622</fpage>–<lpage>16627</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1316240110</pub-id>
<pub-id pub-id-type="pmid">24046374</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>C.-H.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>Z.</given-names></name><name><surname>Yoritomo</surname><given-names>N.</given-names></name><name><surname>Ross</surname><given-names>C. A.</given-names></name><name><surname>Margolis</surname><given-names>R. L.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>16</volume>
<fpage>358</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2011.13</pub-id>
<pub-id pub-id-type="pmid">21339753</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colasante</surname><given-names>G.</given-names></name><name><surname>Lignani</surname><given-names>G.</given-names></name><name><surname>Rubio</surname><given-names>A.</given-names></name><name><surname>Medrihan</surname><given-names>L.</given-names></name><name><surname>Yekhlef</surname><given-names>L.</given-names></name><name><surname>Sessa</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Rapid conversion of fibroblasts into functional forebrain GABAergic interneurons by direct genetic reprogramming.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>17</volume>
<fpage>719</fpage>–<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2015.09.002</pub-id>
<pub-id pub-id-type="pmid">26526726</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>K. L.</given-names></name><name><surname>Stewart</surname><given-names>D. G.</given-names></name><name><surname>Friedman</surname><given-names>J. I.</given-names></name><name><surname>Buchsbaum</surname><given-names>M.</given-names></name><name><surname>Harvey</surname><given-names>P. D.</given-names></name><name><surname>Hof</surname><given-names>P. R.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>White matter changes in schizophrenia: evidence for myelin-related dysfunction.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>60</volume>
<fpage>443</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.60.5.443</pub-id>
<pub-id pub-id-type="pmid">12742865</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delay</surname><given-names>J.</given-names></name><name><surname>Deniker</surname><given-names>P.</given-names></name><name><surname>Harl</surname><given-names>J. M.</given-names></name></person-group> (<year>1952</year>). <article-title>Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP).</article-title>
<source/><italic>Ann. Med. Psychol.</italic> 110 <volume>2</volume>
<fpage>112</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="pmid">12986408</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>X.</given-names></name><name><surname>Chang</surname><given-names>J. H.</given-names></name><name><surname>Ge</surname><given-names>S.</given-names></name><name><surname>Faulkner</surname><given-names>R. L.</given-names></name><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Kitabatake</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in the adult brain.</article-title>
<source/><italic>Cell</italic>
<volume>130</volume>
<fpage>1146</fpage>–<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.07.010</pub-id>
<pub-id pub-id-type="pmid">17825401</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>M.</given-names></name><name><surname>Mozafari</surname><given-names>S.</given-names></name><name><surname>Glatza</surname><given-names>M.</given-names></name><name><surname>Starost</surname><given-names>L.</given-names></name><name><surname>Velychko</surname><given-names>S.</given-names></name><name><surname>Hallmann</surname><given-names>A.-L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>114</volume>
<fpage>E2243</fpage>–<lpage>E2252</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1614412114</pub-id>
<pub-id pub-id-type="pmid">28246330</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>M.</given-names></name><name><surname>Do-Ha</surname><given-names>D.</given-names></name><name><surname>Muñoz</surname><given-names>S. S.</given-names></name><name><surname>Ooi</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<volume>73</volume>
<fpage>3693</fpage>–<lpage>3709</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-016-2265-3</pub-id>
<pub-id pub-id-type="pmid">27154043</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faludi</surname><given-names>G.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Synaptic changes in the brain of subjects with schizophrenia.</article-title>
<source/><italic>Int. J. Dev. Neurosci.</italic>
<volume>29</volume>
<fpage>305</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2011.02.013</pub-id>
<pub-id pub-id-type="pmid">21382468</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>I.</given-names></name></person-group> (<year>1982</year>). <article-title>Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?</article-title>
<source/><italic>J. Psychiatr. Res.</italic>
<volume>17</volume>
<fpage>319</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1016/0022-3956(82)90038-3</pub-id>
<pub-id pub-id-type="pmid">7187776</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Martinez</surname><given-names>A.</given-names></name><name><surname>Boluda</surname><given-names>S.</given-names></name><name><surname>Parchi</surname><given-names>P.</given-names></name><name><surname>Barrachina</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies.</article-title>
<source/><italic>Cell Tissue Bank.</italic>
<volume>9</volume>
<fpage>181</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1007/s10561-008-9077-0</pub-id>
<pub-id pub-id-type="pmid">18543077</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>G.</given-names></name><name><surname>Morales-Medina</surname><given-names>J. C.</given-names></name><name><surname>Diaz</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuronal and brain morphological changes in animal models of schizophrenia.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>301</volume>
<fpage>190</fpage>–<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.12.034</pub-id>
<pub-id pub-id-type="pmid">26738967</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glantz</surname><given-names>L. A.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>57</volume>
<fpage>65</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.1.65</pub-id><pub-id pub-id-type="pmid">10632234</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goudriaan</surname><given-names>A.</given-names></name><name><surname>de Leeuw</surname><given-names>C.</given-names></name><name><surname>Ripke</surname><given-names>S.</given-names></name><name><surname>Hultman</surname><given-names>C. M.</given-names></name><name><surname>Sklar</surname><given-names>P.</given-names></name><name><surname>Sullivan</surname><given-names>P. F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Specific glial functions contribute to schizophrenia susceptibility.</article-title>
<source/><italic>Schizophr. Bull.</italic>
<volume>40</volume>
<fpage>925</fpage>–<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/sbt109</pub-id>
<pub-id pub-id-type="pmid">23956119</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>M.</given-names></name><name><surname>Houdou</surname><given-names>S.</given-names></name><name><surname>Mito</surname><given-names>T.</given-names></name><name><surname>Takashima</surname><given-names>S.</given-names></name><name><surname>Asanuma</surname><given-names>K.</given-names></name><name><surname>Ohno</surname><given-names>T.</given-names></name></person-group> (<year>1992</year>). <article-title>Development of myelination in the human fetal and infant cerebrum: a myelin basic protein immunohistochemical study.</article-title>
<source/><italic>Brain Dev.</italic>
<volume>14</volume>
<fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S0387-7604(12)80271-3</pub-id>
<pub-id pub-id-type="pmid">1375444</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henquet</surname><given-names>C.</given-names></name><name><surname>Murray</surname><given-names>R.</given-names></name><name><surname>Linszen</surname><given-names>D.</given-names></name><name><surname>van Os</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The environment and schizophrenia: the role of cannabis use.</article-title>
<source/><italic>Schizophr. Bull.</italic>
<volume>31</volume>
<fpage>608</fpage>–<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/sbi027</pub-id>
<pub-id pub-id-type="pmid">15976013</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>S.-M.</given-names></name><name><surname>Hartley</surname><given-names>B. J.</given-names></name><name><surname>Tcw</surname><given-names>J.</given-names></name><name><surname>Beaumont</surname><given-names>M.</given-names></name><name><surname>Stafford</surname><given-names>K.</given-names></name><name><surname>Slesinger</surname><given-names>P. A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells.</article-title>
<source/><italic>Methods</italic>
<volume>101</volume>
<fpage>113</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2015.11.019</pub-id>
<pub-id pub-id-type="pmid">26626326</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homayoun</surname><given-names>H.</given-names></name><name><surname>Moghaddam</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>11496</fpage>–<lpage>11500</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2213-07.2007</pub-id>
<pub-id pub-id-type="pmid">17959792</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>C. J.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Victor</surname><given-names>M. B.</given-names></name><name><surname>Dahiya</surname><given-names>S.</given-names></name><name><surname>Batista</surname><given-names>L. F.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts.</article-title>
<source/><italic>eLife</italic>
<volume>5</volume>:<issue>e18648</issue>. <pub-id pub-id-type="doi">10.7554/eLife.18648</pub-id>
<pub-id pub-id-type="pmid">27644593</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttenlocher</surname><given-names>P. R.</given-names></name><name><surname>Dabholkar</surname><given-names>A. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Regional differences in synaptogenesis in human cerebral cortex.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>387</volume>
<fpage>167</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19971020)387:2&lt;167::AID-CNE1&gt;3.0.CO;2-Z</pub-id>
<pub-id pub-id-type="pmid">9336221</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kantrowitz</surname><given-names>J.</given-names></name><name><surname>Javitt</surname><given-names>D. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Glutamatergic transmission in schizophrenia: from basic research to clinical practice.</article-title>
<source/><italic>Curr. Opin. Psychiatry</italic>
<volume>25</volume>
<fpage>96</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1097/YCO.0b013e32835035b2</pub-id>
<pub-id pub-id-type="pmid">22297716</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrer</surname><given-names>C.</given-names></name><name><surname>Maziashvili</surname><given-names>N.</given-names></name><name><surname>Dugladze</surname><given-names>T.</given-names></name><name><surname>Gloveli</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>1</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.3389/neuro.02.006.2008</pub-id>
<pub-id pub-id-type="pmid">18946539</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>B.</given-names></name><name><surname>Buchanan</surname><given-names>R. W.</given-names></name><name><surname>Ross</surname><given-names>D. E.</given-names></name><name><surname>Carpenter</surname><given-names>W. T.</given-names></name></person-group> (<year>2001</year>). <article-title>A separate disease within the syndrome of schizophrenia.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>58</volume>
<fpage>165</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.58.2.165</pub-id><pub-id pub-id-type="pmid">11177118</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreutzberg</surname><given-names>G. W.</given-names></name></person-group> (<year>1996</year>). <article-title>Microglia: a sensor for pathological events in the CNS.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>19</volume>
<fpage>312</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(96)10049-7</pub-id>
<pub-id pub-id-type="pmid">8843599</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijlaars</surname><given-names>J.</given-names></name><name><surname>Oyelami</surname><given-names>T.</given-names></name><name><surname>Diels</surname><given-names>A.</given-names></name><name><surname>Rohrbacher</surname><given-names>J.</given-names></name><name><surname>Versweyveld</surname><given-names>S.</given-names></name><name><surname>Meneghello</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Sustained synchronized neuronal network activity in a human astrocyte co-culture system.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>36529</issue>. <pub-id pub-id-type="doi">10.1038/srep36529</pub-id>
<pub-id pub-id-type="pmid">27819315</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>D. A.</given-names></name><name><surname>Lieberman</surname><given-names>J. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Catching up on schizophrenia: natural history and neurobiology.</article-title>
<source/><italic>Neuron</italic>
<volume>28</volume>
<fpage>325</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)00111-2</pub-id>
<pub-id pub-id-type="pmid">11144342</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>J. A.</given-names></name><name><surname>Scott Stroup</surname><given-names>T.</given-names></name><name><surname>McEvoy</surname><given-names>J. P.</given-names></name><name><surname>Swartz</surname><given-names>M. S.</given-names></name><name><surname>Rosenheck</surname><given-names>R. A.</given-names></name><name><surname>Perkins</surname><given-names>D. O.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.</article-title>
<source/><italic>New Engl. J. Med.</italic>
<volume>353</volume>
<fpage>1209</fpage>–<lpage>1223</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa051688</pub-id>
<pub-id pub-id-type="pmid">16172203</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Pedrosa</surname><given-names>E.</given-names></name><name><surname>Hrabovsky</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Puliafito</surname><given-names>B. R.</given-names></name><name><surname>Gilbert</surname><given-names>S. R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion.</article-title>
<source/><italic>BMC Syst. Biol.</italic>
<volume>10</volume>:<issue>105</issue>. <pub-id pub-id-type="doi">10.1186/s12918-016-0366-0</pub-id>
<pub-id pub-id-type="pmid">27846841</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livesey</surname><given-names>M. R.</given-names></name><name><surname>Magnani</surname><given-names>D.</given-names></name><name><surname>Cleary</surname><given-names>E. M.</given-names></name><name><surname>Vasistha</surname><given-names>N. A.</given-names></name><name><surname>James</surname><given-names>O. T.</given-names></name><name><surname>Selvaraj</surname><given-names>B. T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.</article-title>
<source/><italic>Stem Cells</italic>
<volume>34</volume>
<fpage>1040</fpage>–<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1002/stem.2273</pub-id>
<pub-id pub-id-type="pmid">26763608</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maroof</surname><given-names>A. M.</given-names></name><name><surname>Keros</surname><given-names>S.</given-names></name><name><surname>Tyson</surname><given-names>J. A.</given-names></name><name><surname>Ying</surname><given-names>S.-W.</given-names></name><name><surname>Ganat</surname><given-names>Y. M.</given-names></name><name><surname>Merkle</surname><given-names>F. T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>12</volume>
<fpage>559</fpage>–<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2013.04.008</pub-id>
<pub-id pub-id-type="pmid">23642365</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGlashan</surname><given-names>T. H.</given-names></name><name><surname>Hoffman</surname><given-names>R. E.</given-names></name></person-group> (<year>2000</year>). <article-title>Schizophrenia as a disorder of developmentally reduced synaptic connectivity.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>57</volume>
<fpage>637</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.7.637</pub-id><pub-id pub-id-type="pmid">10891034</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mertens</surname><given-names>J.</given-names></name><name><surname>Paquola</surname><given-names>A. C.</given-names></name><name><surname>Ku</surname><given-names>M.</given-names></name><name><surname>Hatch</surname><given-names>E.</given-names></name><name><surname>Böhnke</surname><given-names>L.</given-names></name><name><surname>Ladjevardi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>17</volume>
<fpage>705</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2015.09.001</pub-id>
<pub-id pub-id-type="pmid">26456686</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monji</surname><given-names>A.</given-names></name><name><surname>Kato</surname><given-names>T. A.</given-names></name><name><surname>Mizoguchi</surname><given-names>Y.</given-names></name><name><surname>Horikawa</surname><given-names>H.</given-names></name><name><surname>Seki</surname><given-names>Y.</given-names></name><name><surname>Kasai</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Neuroinflammation in schizophrenia especially focused on the role of microglia.</article-title>
<source/><italic>Prog. NeuroPsychopharmacol. Biol. Psychiatry</italic>
<volume>42</volume>
<fpage>115</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2011.12.002</pub-id>
<pub-id pub-id-type="pmid">22192886</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muffat</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><name><surname>Mitalipova</surname><given-names>M.</given-names></name><name><surname>Omer</surname><given-names>A.</given-names></name><name><surname>Corcoran</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Efficient Derivation of microglia-like cells from human pluripotent stem cells.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>22</volume>
<fpage>1358</fpage>–<lpage>1367</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4189</pub-id>
<pub-id pub-id-type="pmid">27668937</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muratore</surname><given-names>C. R.</given-names></name><name><surname>Srikanth</surname><given-names>P.</given-names></name><name><surname>Callahan</surname><given-names>D. G.</given-names></name><name><surname>Young-Pearse</surname><given-names>T. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Comparison and optimization of hiPSC forebrain cortical differentiation protocols.</article-title>
<source/><italic>PLOS ONE</italic>
<volume>9</volume>:<issue>e105807</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0105807</pub-id>
<pub-id pub-id-type="pmid">25165848</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholas</surname><given-names>C. R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Southwell</surname><given-names>D. G.</given-names></name><name><surname>Chalmers</surname><given-names>N.</given-names></name><name><surname>Vogt</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>12</volume>
<fpage>573</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2013.04.005</pub-id>
<pub-id pub-id-type="pmid">23642366</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odawara</surname><given-names>A.</given-names></name><name><surname>Saitoh</surname><given-names>Y.</given-names></name><name><surname>Alhebshi</surname><given-names>A. H.</given-names></name><name><surname>Gotoh</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Long-term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>443</volume>
<fpage>1176</fpage>–<lpage>1181</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.12.142</pub-id>
<pub-id pub-id-type="pmid">24406164</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olney</surname><given-names>J. W.</given-names></name><name><surname>Newcomer</surname><given-names>J. W.</given-names></name><name><surname>Farber</surname><given-names>N. B.</given-names></name></person-group> (<year>1999</year>). <article-title>NMDA receptor hypofunction model of schizophrenia.</article-title>
<source/><italic>J. Psychiatr. Res.</italic>
<volume>33</volume>
<fpage>523</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3956(99)00029-1</pub-id><pub-id pub-id-type="pmid">10628529</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname><given-names>C.</given-names></name><name><surname>Danko</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Aoto</surname><given-names>J.</given-names></name><name><surname>Anderson</surname><given-names>A.</given-names></name><name><surname>Maxeiner</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>17</volume>
<fpage>316</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2015.07.017</pub-id>
<pub-id pub-id-type="pmid">26279266</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>M. J.</given-names></name><name><surname>Ichikawa</surname><given-names>D. M.</given-names></name><name><surname>Sedlock</surname><given-names>A. B.</given-names></name><name><surname>Choi</surname><given-names>Y.</given-names></name><name><surname>Johnson</surname><given-names>K. R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Differentiation of human and murine induced pluripotent stem cells to microglia-like cells.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>20</volume>
<fpage>753</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4534</pub-id>
<pub-id pub-id-type="pmid">28253233</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Scianni</surname><given-names>M.</given-names></name><name><surname>Panzanelli</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Synaptic pruning by microglia is necessary for normal brain development.</article-title>
<source/><italic>Science</italic>
<volume>333</volume>
<fpage>1456</fpage>–<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.1126/science.1202529</pub-id>
<pub-id pub-id-type="pmid">21778362</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paşca</surname><given-names>A. M.</given-names></name><name><surname>Sloan</surname><given-names>S. A.</given-names></name><name><surname>Clarke</surname><given-names>L. E.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Makinson</surname><given-names>C. D.</given-names></name><name><surname>Huber</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Functional cortical neurons and astrocytes from human pluripotent stem cells in 3d culture.</article-title>
<source/><italic>Nat. Methods</italic>
<volume>12</volume>
<fpage>671</fpage>–<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3415</pub-id>
<pub-id pub-id-type="pmid">26005811</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedrosa</surname><given-names>E.</given-names></name><name><surname>Sandler</surname><given-names>V.</given-names></name><name><surname>Shah</surname><given-names>A.</given-names></name><name><surname>Carroll</surname><given-names>R.</given-names></name><name><surname>Chang</surname><given-names>C.</given-names></name><name><surname>Rockowitz</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells.</article-title>
<source/><italic>J. Neurogenet.</italic>
<volume>25</volume>
<fpage>88</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.3109/01677063.2011.597908</pub-id>
<pub-id pub-id-type="pmid">21797804</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porteous</surname><given-names>D. J.</given-names></name><name><surname>Thomson</surname><given-names>P. A.</given-names></name><name><surname>Millar</surname><given-names>J. K.</given-names></name><name><surname>Evans</surname><given-names>K. L.</given-names></name><name><surname>Hennah</surname><given-names>W.</given-names></name><name><surname>Soares</surname><given-names>D. C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>141</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.160</pub-id>
<pub-id pub-id-type="pmid">24457522</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X.</given-names></name><name><surname>Nguyen</surname><given-names>H. N.</given-names></name><name><surname>Song</surname><given-names>M. M.</given-names></name><name><surname>Hadiono</surname><given-names>C.</given-names></name><name><surname>Ogden</surname><given-names>S. C.</given-names></name><name><surname>Hammack</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure.</article-title>
<source/><italic>Cell</italic>
<volume>165</volume>
<fpage>1238</fpage>–<lpage>1254</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.04.032</pub-id>
<pub-id pub-id-type="pmid">27118425</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Read</surname><given-names>J.</given-names></name><name><surname>van Os</surname><given-names>J.</given-names></name><name><surname>Morrison</surname><given-names>A. P.</given-names></name><name><surname>Ross</surname><given-names>C. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications.</article-title>
<source/><italic>Acta Psychiatr. Scand.</italic>
<volume>112</volume>
<fpage>330</fpage>–<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.2005.00634.x</pub-id>
<pub-id pub-id-type="pmid">16223421</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rössler</surname><given-names>W.</given-names></name><name><surname>Salize</surname><given-names>H. J.</given-names></name><name><surname>van Os</surname><given-names>J.</given-names></name><name><surname>Riecher-Rössler</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Size of burden of schizophrenia and psychotic disorders.</article-title>
<source/><italic>Eur. Neuropsychopharmacol.</italic>
<volume>15</volume>
<fpage>399</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2005.04.009</pub-id>
<pub-id pub-id-type="pmid">15925493</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab> (<year>2014</year>). <article-title>Biological insights from 108 schizophrenia-associated genetic loci.</article-title>
<source/><italic>Nature</italic>
<volume>511</volume>
<fpage>421</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
<pub-id pub-id-type="pmid">25056061</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekar</surname><given-names>A.</given-names></name><name><surname>Bialas</surname><given-names>A. R.</given-names></name><name><surname>de Rivera</surname><given-names>H.</given-names></name><name><surname>Davis</surname><given-names>A.</given-names></name><name><surname>Hammond</surname><given-names>T. R.</given-names></name><name><surname>Kamitaki</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Schizophrenia risk from complex variation of complement component 4.</article-title>
<source/><italic>Nature</italic>
<volume>530</volume>
<fpage>177</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1038/nature16549</pub-id>
<pub-id pub-id-type="pmid">26814963</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Kirwan</surname><given-names>P.</given-names></name><name><surname>Livesey</surname><given-names>F. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks.</article-title>
<source/><italic>Nat. Protoc.</italic>
<volume>7</volume>
<fpage>1836</fpage>–<lpage>1846</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2012.116</pub-id>
<pub-id pub-id-type="pmid">22976355</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Clair</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Copy number variation and schizophrenia.</article-title>
<source/><italic>Schizophr. Bull.</italic>
<volume>35</volume>
<fpage>9</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/sbn147</pub-id>
<pub-id pub-id-type="pmid">18990708</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>I. K.</given-names></name><name><surname>Vanderhaeghen</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Is this a brain which i see before me? Modeling human neural development with pluripotent stem cells.</article-title>
<source/><italic>Development</italic>
<volume>142</volume>
<fpage>3138</fpage>–<lpage>3150</lpage>. <pub-id pub-id-type="doi">10.1242/dev.120568</pub-id>
<pub-id pub-id-type="pmid">26395142</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Tanabe</surname><given-names>K.</given-names></name><name><surname>Ohnuki</surname><given-names>M.</given-names></name><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Ichisaka</surname><given-names>T.</given-names></name><name><surname>Tomoda</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Induction of pluripotent stem cells from adult human fibroblasts by defined factors.</article-title>
<source/><italic>Cell</italic>
<volume>131</volume>
<fpage>861</fpage>–<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.11.019</pub-id>
<pub-id pub-id-type="pmid">18035408</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Davis</surname><given-names>K. L.</given-names></name><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>93</volume>
<fpage>13</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.09.004</pub-id>
<pub-id pub-id-type="pmid">20950668</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Wagner</surname><given-names>A. M.</given-names></name><name><surname>Marchetto</surname><given-names>M. C. N.</given-names></name><name><surname>Muotri</surname><given-names>A. R.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Astroglial cells regulate the developmental timeline of human neurons differentiated from induced pluripotent stem cells.</article-title>
<source/><italic>Stem Cell Res.</italic>
<volume>11</volume>
<fpage>743</fpage>–<lpage>757</lpage>. <pub-id pub-id-type="doi">10.1016/j.scr.2013.05.002</pub-id>
<pub-id pub-id-type="pmid">23759711</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tkachev</surname><given-names>D.</given-names></name><name><surname>Mimmack</surname><given-names>M. L.</given-names></name><name><surname>Ryan</surname><given-names>M. M.</given-names></name><name><surname>Wayland</surname><given-names>M.</given-names></name><name><surname>Freeman</surname><given-names>T.</given-names></name><name><surname>Jones</surname><given-names>P. B.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.</article-title>
<source/><italic>Lancet</italic>
<volume>362</volume>
<fpage>798</fpage>–<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(03)14289-4</pub-id><pub-id pub-id-type="pmid">13678875</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoshima</surname><given-names>M.</given-names></name><name><surname>Akamatsu</surname><given-names>W.</given-names></name><name><surname>Okada</surname><given-names>Y.</given-names></name><name><surname>Ohnishi</surname><given-names>T.</given-names></name><name><surname>Balan</surname><given-names>S.</given-names></name><name><surname>Hisano</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>6</volume> e934. <pub-id pub-id-type="doi">10.1038/tp.2016.206</pub-id>
<pub-id pub-id-type="pmid">27801899</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Os</surname><given-names>J.</given-names></name><name><surname>Kenis</surname><given-names>G.</given-names></name><name><surname>Rutten</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>The environment and schizophrenia.</article-title>
<source/><italic>Nature</italic>
<volume>468</volume>
<fpage>203</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1038/nature09563</pub-id>
<pub-id pub-id-type="pmid">21068828</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>D. R.</given-names></name></person-group> (<year>1995</year>). <article-title>From neuropathology to neurodevelopment.</article-title>
<source/><italic>Lancet</italic>
<volume>346</volume>
<fpage>552</fpage>–<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(95)91386-6</pub-id><pub-id pub-id-type="pmid">7544856</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Z.</given-names></name><name><surname>Nguyen</surname><given-names>H. N.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Lalli</surname><given-names>M. A.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Synaptic dysregulation in a human iPS cell model of mental disorders.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>414</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1038/nature13716</pub-id>
<pub-id pub-id-type="pmid">25132547</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>M. R.</given-names></name><name><surname>Hampton</surname><given-names>T.</given-names></name><name><surname>Pearce</surname><given-names>R. K. B.</given-names></name><name><surname>Hirsch</surname><given-names>S. R.</given-names></name><name><surname>Ansorge</surname><given-names>O.</given-names></name><name><surname>Thom</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia.</article-title>
<source/><italic>Eur. Arch. Psychiatry Clin. Neurosci.</italic>
<volume>263</volume>
<fpage>41</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1007/s00406-012-0328-5</pub-id>
<pub-id pub-id-type="pmid">22660922</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windrem</surname><given-names>M. S.</given-names></name><name><surname>Osipovitch</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Bates</surname><given-names>J.</given-names></name><name><surname>Chandler-Militello</surname><given-names>D.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>21</volume>
<issue>195</issue>.<fpage>e6</fpage>–<lpage>208</lpage>.e6. <pub-id pub-id-type="doi">10.1016/j.stem.2017.06.012</pub-id>
<pub-id pub-id-type="pmid">28736215</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>K.-J.</given-names></name><name><surname>Nguyen</surname><given-names>H. N.</given-names></name><name><surname>Ursini</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Kim</surname><given-names>N.-S.</given-names></name><name><surname>Wen</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>15</volume>
<fpage>79</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2014.05.003</pub-id>
<pub-id pub-id-type="pmid">24996170</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D. X.</given-names></name><name><surname>Di Giorgio</surname><given-names>F. P.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Marchetto</surname><given-names>M. C.</given-names></name><name><surname>Brennand</surname><given-names>K.</given-names></name><name><surname>Wright</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Modeling hippocampal neurogenesis using human pluripotent stem cells.</article-title>
<source/><italic>Stem Cell Rep.</italic>
<volume>2</volume>
<fpage>295</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2014.01.009</pub-id>
<pub-id pub-id-type="pmid">24672753</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Yamamoto</surname><given-names>V.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models.</article-title>
<source/><italic>PLOS ONE</italic>
<volume>8</volume>:<issue>e59685</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059685</pub-id>
<pub-id pub-id-type="pmid">23536886</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>D.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Pedrosa</surname><given-names>E.</given-names></name><name><surname>Hrabovsky</surname><given-names>A.</given-names></name><name><surname>Fourcade</surname><given-names>H. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>MicroRNA profiling of neurons generated using induced pluripotent stem cells derived from patients with schizophrenia and schizoaffective disorder, and 22q11.2 del.</article-title>
<source/><italic>PLOS ONE</italic>
<volume>10</volume>:<issue>e0132387</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0132387</pub-id>
<pub-id pub-id-type="pmid">26173148</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>